Visionary Asset Management Inc. acquired a new stake in shares of Hill-Rom Holdings Inc (NYSE:HRC) during the second quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm acquired 4,669 shares of the medical technology company’s stock, valued at approximately $372,000.
Several other large investors also recently modified their holdings of the company. Louisiana State Employees Retirement System boosted its position in Hill-Rom Holdings by 4.0% in the second quarter. Louisiana State Employees Retirement System now owns 15,600 shares of the medical technology company’s stock valued at $1,242,000 after buying an additional 600 shares during the last quarter. LS Investment Advisors LLC boosted its position in Hill-Rom Holdings by 19.4% in the second quarter. LS Investment Advisors LLC now owns 5,012 shares of the medical technology company’s stock valued at $399,000 after buying an additional 815 shares during the last quarter. Oregon Public Employees Retirement Fund boosted its position in Hill-Rom Holdings by 4.6% in the second quarter. Oregon Public Employees Retirement Fund now owns 21,882 shares of the medical technology company’s stock valued at $1,742,000 after buying an additional 969 shares during the last quarter. Eqis Capital Management Inc. boosted its position in shares of Hill-Rom Holdings by 16.0% in the second quarter. Eqis Capital Management Inc. now owns 5,415 shares of the medical technology company’s stock worth $431,000 after buying an additional 745 shares in the last quarter. Finally, James Investment Research Inc. purchased a new position in shares of Hill-Rom Holdings during the second quarter worth $1,401,000. 84.00% of the stock is owned by hedge funds and other institutional investors.
Shares of Hill-Rom Holdings Inc (NYSE HRC) traded up 0.37% during midday trading on Friday, hitting $73.72. The stock had a trading volume of 355,241 shares. The firm has a market cap of $4.86 billion, a PE ratio of 42.96 and a beta of 1.22. The firm has a 50-day moving average of $79.48 and a 200 day moving average of $72.76. Hill-Rom Holdings Inc has a 12-month low of $50.50 and a 12-month high of $84.65.
Hill-Rom Holdings (NYSE:HRC) last issued its quarterly earnings data on Friday, July 28th. The medical technology company reported $0.91 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.90 by $0.01. Hill-Rom Holdings had a return on equity of 19.99% and a net margin of 4.27%. The company had revenue of $689.10 million during the quarter, compared to analysts’ expectations of $695.50 million. During the same quarter in the previous year, the company posted $0.81 earnings per share. The business’s revenue was up 5.1% on a year-over-year basis. On average, analysts expect that Hill-Rom Holdings Inc will post $3.82 earnings per share for the current year.
The company also recently disclosed a quarterly dividend, which will be paid on Friday, September 29th. Stockholders of record on Friday, September 15th will be issued a dividend of $0.18 per share. This represents a $0.72 dividend on an annualized basis and a dividend yield of 0.98%. The ex-dividend date of this dividend is Thursday, September 14th. Hill-Rom Holdings’s dividend payout ratio is presently 41.62%.
TRADEMARK VIOLATION NOTICE: This article was first published by BNB Daily and is owned by of BNB Daily. If you are reading this article on another website, it was stolen and reposted in violation of United States & international copyright legislation. The correct version of this article can be read at https://www.baseball-news-blog.com/2017/08/14/visionary-asset-management-inc-invests-372000-in-hill-rom-holdings-inc-nysehrc-updated-updated-updated.html.
A number of research analysts have recently weighed in on the company. BidaskClub lowered Hill-Rom Holdings from a “buy” rating to a “hold” rating in a research note on Monday, July 31st. Zacks Investment Research lowered Hill-Rom Holdings from a “hold” rating to a “sell” rating in a research note on Wednesday, August 2nd. Cantor Fitzgerald set a $86.00 price target on Hill-Rom Holdings and gave the stock a “hold” rating in a research note on Friday, July 28th. Stifel Nicolaus reissued a “buy” rating and issued a $84.00 price target on shares of Hill-Rom Holdings in a research note on Sunday, July 30th. Finally, Needham & Company LLC reduced their price objective on Hill-Rom Holdings from $95.00 to $93.00 and set a “buy” rating on the stock in a research note on Friday, July 28th. One equities research analyst has rated the stock with a sell rating, two have given a hold rating and five have issued a buy rating to the company. The company has an average rating of “Buy” and a consensus price target of $88.17.
In other news, SVP Paul Sherwood Johnson sold 2,078 shares of the business’s stock in a transaction that occurred on Wednesday, May 17th. The stock was sold at an average price of $72.30, for a total transaction of $150,239.40. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. Also, SVP Andreas G. Frank sold 10,660 shares of the business’s stock in a transaction that occurred on Tuesday, June 6th. The stock was sold at an average price of $78.62, for a total value of $838,089.20. Following the sale, the senior vice president now owns 28,988 shares of the company’s stock, valued at approximately $2,279,036.56. The disclosure for this sale can be found here. Insiders own 2.20% of the company’s stock.
About Hill-Rom Holdings
Hill-Rom Holdings, Inc is a global medical technology company. The Company operates through four segments: North America Patient Support Systems, International Patient Support Systems, Front Line Care and Surgical Solutions. The Company’s products and services include Patient Support Systems, Front Line Care and Surgical Solutions.
Receive News & Ratings for Hill-Rom Holdings Inc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Hill-Rom Holdings Inc and related companies with MarketBeat.com's FREE daily email newsletter.